{
  "ticker": "TRI",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970013",
  "id": "02970013",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250717",
  "time": "0827",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250717/pdf/06lw3np4hkwtd1.pdf",
  "summary": "**Summary of ASX Announcement (TrivarX Limited, 17 July 2025):**  \n\n- **Clinical Trial Update:** Recruitment progressing well for TrivarX's single-lead ECG trial targeting major depressive episodes (cMDE) in veterans.  \n- **Enrollment Status:** 10 patients completed trial procedures; on track to reach target of 30 patients by mid-September 2025.  \n- **Key Partnership:** Collaboration with GLAVREF and VA Greater Los Angeles Healthcare System remains strong.  \n\n*No material capital markets or trading-specific information identified.*",
  "usage": {
    "prompt_tokens": 985,
    "completion_tokens": 119,
    "total_tokens": 1104,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T22:37:57.065971"
}